Methodology

All entries for: Catalysis Therapeutics Inc.

May 18, 2026

Catalysis Therapeutics Inc.

Orphan Drug Designation

treatment of soft tissue sarcoma

Disease Area: Rare Diseases
Source
Scroll to Top